FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3193308767> ?p ?o ?g. }

• W3193308767 endingPage "100111" @default.
• W3193308767 startingPage "100111" @default.
• W3193308767 abstract "Breast cancer has the most commonly diagnosed malignancy cancer worldwide in women and has a high mortality. Various anticancer drugs to treat breast cancer have been developed and tested but have failed because of drug resistance. The efficacy of SH003 against doxorubicin-resistant MCF/ADR cells has not been evaluated. In this study, we aimed to examine whether SH003 could efficiently prevent the proliferation of MCF7/ADR cells. Cell viability was measured by an MTT assay. Analysis of cell cycle arrest was performed by flow cytometry. Induction of apoptosis by SH003 was measured by an annexin V-FITC/PI assay. Levels of p-STAT3, p-PD-L1, MDR and caspases were measured by western blot analysis. mRNA expression levels of MDR1, MRP1, -2, -3, -4, -5, -6, -9, BCRP and PD-L1 were measured by RT-PCR. Nuclear staining of STAT3 was measured by immunocytochemistry. The expression levels of VEGF, MMP-2 and MMP-9 were measured by ELISA. SH003 inhibited the proliferation of MCF7/ADR cells and induced their sub-G1 cell cycle arrest. SH003 also induced apoptosis, regulated apoptotic molecules, caused morphological changes and inhibited colony formation in MCF7/ADR cells. Furthermore, SH003 suppressed STAT3 transcriptional activity and, more importantly, reduced the cytokine levels of VEGF, MMP-2 and MMP-9 in MCF7/ADR cells. SH003 decreased the protein expression of PD-L1 and MDR1. Additionally, SH003 reduced the mRNA expression of PD-L1; MDR1; MRP1, -2, -3, -4, -5, -6, and -9; and BCRP. Our results clearly demonstrate that SH003 inhibits cell growth and induces apoptosis by inhibiting STAT3 signaling. Additionally, SH003 decreased the levels of MDR1 and PD-L1 by inhibiting STAT3 signaling in MCF7/ADR breast cancer cells. These results support the possibility that SH003 could be useful as an herbal medicine to treat doxorubicin-resistant breast cancer." @default.
• W3193308767 created "2021-08-30" @default.
• W3193308767 creator A5001023562 @default.
• W3193308767 creator A5011068004 @default.
• W3193308767 creator A5011105974 @default.
• W3193308767 creator A5049362745 @default.
• W3193308767 creator A5049834556 @default.
• W3193308767 creator A5052136007 @default.
• W3193308767 creator A5058202763 @default.
• W3193308767 creator A5074067628 @default.
• W3193308767 creator A5076764666 @default.
• W3193308767 date "2021-11-01" @default.
• W3193308767 modified "2023-10-16" @default.
• W3193308767 title "SH003 overcomes drug resistance and immune checkpoints by inhibiting JAK-STAT3 signaling in MCF7/ADR cells" @default.
• W3193308767 cites W1487283858 @default.
• W3193308767 cites W1503987109 @default.
• W3193308767 cites W1770161268 @default.
• W3193308767 cites W1809197747 @default.
• W3193308767 cites W1913780655 @default.
• W3193308767 cites W1942897646 @default.
• W3193308767 cites W1963987641 @default.
• W3193308767 cites W1970747178 @default.
• W3193308767 cites W1973256703 @default.
• W3193308767 cites W1981467511 @default.
• W3193308767 cites W1984760649 @default.
• W3193308767 cites W1985527927 @default.
• W3193308767 cites W1986944635 @default.
• W3193308767 cites W1990665786 @default.
• W3193308767 cites W1995997868 @default.
• W3193308767 cites W1997283322 @default.
• W3193308767 cites W2001472847 @default.
• W3193308767 cites W2003681585 @default.
• W3193308767 cites W2006434892 @default.
• W3193308767 cites W2019633596 @default.
• W3193308767 cites W2021505095 @default.
• W3193308767 cites W2025689023 @default.
• W3193308767 cites W2038121235 @default.
• W3193308767 cites W2055904567 @default.
• W3193308767 cites W2058215061 @default.
• W3193308767 cites W2066671159 @default.
• W3193308767 cites W2071547598 @default.
• W3193308767 cites W2072001961 @default.
• W3193308767 cites W2077391866 @default.
• W3193308767 cites W2085708608 @default.
• W3193308767 cites W2087628066 @default.
• W3193308767 cites W2089123544 @default.
• W3193308767 cites W2113231588 @default.
• W3193308767 cites W2117692326 @default.
• W3193308767 cites W2123373938 @default.
• W3193308767 cites W2131620884 @default.
• W3193308767 cites W2135437515 @default.
• W3193308767 cites W2139041495 @default.
• W3193308767 cites W2141736687 @default.
• W3193308767 cites W2151950281 @default.
• W3193308767 cites W2157985882 @default.
• W3193308767 cites W2171490806 @default.
• W3193308767 cites W2292383635 @default.
• W3193308767 cites W2312957701 @default.
• W3193308767 cites W2337192094 @default.
• W3193308767 cites W2552820307 @default.
• W3193308767 cites W2558677829 @default.
• W3193308767 cites W2561601648 @default.
• W3193308767 cites W2609996476 @default.
• W3193308767 cites W2614719195 @default.
• W3193308767 cites W2762401006 @default.
• W3193308767 cites W2766852052 @default.
• W3193308767 cites W2786987313 @default.
• W3193308767 cites W2898747120 @default.
• W3193308767 cites W2961185444 @default.
• W3193308767 cites W3128646645 @default.
• W3193308767 cites W4241664300 @default.
• W3193308767 doi "https://doi.org/10.1016/j.phyplu.2021.100111" @default.
• W3193308767 hasPublicationYear "2021" @default.
• W3193308767 type Work @default.
• W3193308767 sameAs 3193308767 @default.
• W3193308767 citedByCount "2" @default.
• W3193308767 countsByYear W31933087672022 @default.
• W3193308767 countsByYear W31933087672023 @default.
• W3193308767 crossrefType "journal-article" @default.
• W3193308767 hasAuthorship W3193308767A5001023562 @default.
• W3193308767 hasAuthorship W3193308767A5011068004 @default.
• W3193308767 hasAuthorship W3193308767A5011105974 @default.
• W3193308767 hasAuthorship W3193308767A5049362745 @default.
• W3193308767 hasAuthorship W3193308767A5049834556 @default.
• W3193308767 hasAuthorship W3193308767A5052136007 @default.
• W3193308767 hasAuthorship W3193308767A5058202763 @default.
• W3193308767 hasAuthorship W3193308767A5074067628 @default.
• W3193308767 hasAuthorship W3193308767A5076764666 @default.
• W3193308767 hasBestOaLocation W31933087671 @default.
• W3193308767 hasConcept C105696609 @default.
• W3193308767 hasConcept C121608353 @default.
• W3193308767 hasConcept C126322002 @default.
• W3193308767 hasConcept C153911025 @default.
• W3193308767 hasConcept C185592680 @default.
• W3193308767 hasConcept C190283241 @default.
• W3193308767 hasConcept C2778923194 @default.
• W3193308767 hasConcept C2780783641 @default.
• W3193308767 hasConcept C29537977 @default.

• next